DEVICE USER FEE PASSAGE THIS SESSION IN DOUBT
This article was originally published in The Gray Sheet
Executive Summary
DEVICE USER FEE PASSAGE THIS SESSION IN DOUBT as Congress nears the end of the legislative session. Factors working against passage of the Medical Device User Fee Act (HR 4864/S 2276), staffers say, include Congress' full agenda, members' desire to return to their districts and campaign for re-election, and a partisan debate on health care reform that is affecting negotiations on other legislation. The device user fee bill, which was introduced in the House and Senate on July 12 ("The Gray Sheet" July 18, p. 1), would impose fees on premarket applications for medical devices; the funds would be applied toward review functions within FDA's Center for Devices and Radiological Health. On the House side, the Energy and Commerce Committee approved the bill on Aug. 9 by a vote of 31 to 13 ("The Gray Sheet" Aug. 15, p. 1). The Senate has yet to take any action on the measure.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.